Can spirometry parameters such as forced expiratory volume in 3 seconds (FEV3), forced expiratory volume in 6 seconds (FEV6), and forced expiratory flow at 25‑75% of vital capacity (FEF25‑75) determine small airway disease, and how do they correlate with impulse oscillometry parameters (e.g., resistance at 5 Hz (R5), resistance at 20 Hz (R20), R5‑R20 difference, reactance at 5 Hz (X5), and area of reactance (AX))?

Can Spirometry Parameters Determine Small Airway Disease and How Do They Correlate with Impulse Oscillometry?

FEF25-75% (forced expiratory flow at 25-75% of vital capacity) is the most clinically useful spirometry parameter for detecting small airway disease (SAD), while FEV3 and FEV6 have limited evidence for this purpose, and impulse oscillometry parameters (particularly R5-R20 and X5) provide complementary information that correlates with spirometric markers of SAD.

Spirometry Parameters for Small Airway Disease Detection

FEF25-75% (Mid-Expiratory Flow)

FEF25-75% is the most established spirometric marker for SAD:

• High sensitivity for early disease: FEF25-75% < 65% of predicted identifies SAD in 82% of asthma patients and 50% of symptomatic smokers without conventional airflow limitation 1
• Superior predictive value: FEF25-75% demonstrates greater discriminatory power than FEV1 for predicting severe asthma (AUC 0.84 vs 0.81), airflow obstruction (0.97 vs 0.89), and severe bronchial hyperresponsiveness (0.74 vs 0.69) 2
• Detects pre-clinical disease: Patients with low FEF25-75% but normal FEV1/FVC show lower spirometric measures and evidence of early pathological lung damage 1
• Correlates with disease burden: In COPD, lower FEF25-75% associates with increased emphysema, functional small airways disease, air trapping, and bronchodilator responsiveness even after adjusting for FEV1 3

Important caveat: The 2005 ERS guidelines note that abnormalities in mid-range flow measurements "are not specific for small airway disease in individual patients" 4, reflecting concerns about reproducibility, particularly in children. However, more recent evidence (2021-2022) demonstrates clinical utility when properly interpreted 1, 2.

FEV3-Related Parameters

• TEV/FEV3 ratio (Terminal Expiration Volume/FEV3, where TEV = FEV3 - FEV1) shows promise as a coherent marker of SAD in pediatric asthma 5
• TEV/FEV3 was significantly higher in children with asthma (17.1 ± 5.5) versus non-asthma (12.0 ± 4.4) and increased with asthma severity 5
• Limitation: FEV3 could only be obtained in 85.4% of children, and those unable to achieve FEV3 had unreliable FEF25-75% measurements 5
• Limited evidence exists for FEV3 as a standalone parameter in adults for SAD detection

FEV6

No specific evidence was provided regarding FEV6's utility for detecting SAD in the available literature.

Correlation with Impulse Oscillometry Parameters

Key IOS Parameters for SAD

The 2003 ERS guidelines on forced oscillation technique establish that 6:

• Resistance at low frequencies (R5): Increased in airway obstruction, particularly sensitive to peripheral airway narrowing
• R5-R20 difference: Negative frequency-dependence of resistance is characteristic of small airway obstruction; greater differences indicate more peripheral disease
• Reactance at 5 Hz (X5): Decreased (more negative) in obstructive disease, reflects elastic properties and peripheral airway function
• Resonant frequency (fres): Increased in obstruction

Correlation Patterns

Complementary information: IOS parameters provide physiological data that correlates with but extends beyond spirometric findings:

• Both FEF25-75% and IOS parameters (R5-R20, X5) detect peripheral airway dysfunction, but IOS is effort-independent 6
• The "negative frequency-dependence of Rrs" (resistance increasing at lower frequencies) parallels the concave flow-volume curve pattern seen with reduced FEF25-75% 4, 6
• IOS may detect SAD when spirometry appears normal, as it's more sensitive to mechanical inhomogeneities 6

Clinical integration: Recent evidence suggests using both modalities together optimizes SAD detection 7, 8:

• Oscillometry parameters (R5-R20, X5, AX) improved significantly alongside FEF25-75% when treating SAD in severe asthma 8
• IOS provides additional value in patients unable to perform maximal forced expiratory maneuvers 4

Practical Clinical Algorithm

For detecting and monitoring SAD:

1. Initial screening: Measure FEF25-75% on standard spirometry

   • Abnormal if < 65% predicted 1, 2
   • Calculate z-score < -0.8345 for more precise cutoff 1

2. If FEV1/FVC normal but FEF25-75% reduced:

   • This identifies early SAD before conventional obstruction develops 1
   • Consider IOS to confirm peripheral airway dysfunction (elevated R5-R20, decreased X5)

3. If spirometry quality questionable or patient effort-limited:

   • Prioritize IOS as it's effort-independent 6
   • Look for R5-R20 > normal range and X5 more negative than predicted

4. For monitoring treatment response:

   • Track both FEF25-75% and IOS parameters (R5-R20, X5) as they improve in parallel with effective SAD treatment 8

Critical Limitations

• Reproducibility concerns: FEF25-75% has higher variability than FEV1, especially in children 4, 5
• Non-specificity: Reduced mid-expiratory flows can occur with submaximal effort or upper airway obstruction 4, 6
• Reference equations: Ensure appropriate predicted values for patient demographics 4
• Interpretation context: Always consider clinical presentation; isolated abnormalities require cautious interpretation 4